PMID- 36864471 OWN - NLM STAT- MEDLINE DCOM- 20230306 LR - 20230306 IS - 1749-799X (Electronic) IS - 1749-799X (Linking) VI - 18 IP - 1 DP - 2023 Mar 2 TI - Effect study of exosomes derived from platelet-rich plasma in the treatment of knee cartilage defects in rats. PG - 160 LID - 10.1186/s13018-023-03576-0 [doi] LID - 160 AB - BACKGROUND: The repair of articular cartilage defects has always been a difficult problem. We aimed to investigate the therapeutic effect of intra-articular injection of platelet-rich plasma (RPR) and PRP-derived exosomes (PRP-Exos) on cartilage defects in rat knee joints and then provide experience for the use of PRP-exos in cartilage defect repair. METHODS: Rat abdominal aortic blood was collected, and PRP was extracted by two-step centrifugation. PRP-exos were obtained by kit extraction, and PRP-exos were identified by various methods. After the rats were anesthetized, a cartilage defect subchondral bone was created at the proximal end of the origin of the femoral cruciate ligament with a drill. SD rats were divided into 4 groups, including PRP group, 50 mug/ml PRP-exos group, 5 mug/ml PRP-exos group, and control group. One week after the operation, 50 mug/ml PRP, 50 mug/ml PRP-exos, 5 mug/ml PRP-exos and normal saline were injected into the knee joint cavity of rats in each group, once a week. A total of two injections were given. On the 5th and 10th week after drug injection, the serum levels of matrix metalloproteinase 3 (MMP-3) and tissue inhibitor of matrix metalloproteinase 1 (TIMP-1) were detected by each treatment method, respectively. The rats were killed at the 5th and 10th weeks, respectively, and the cartilage defect repair was observed and scored. The defect repair tissue sections were used for HE staining and type II collagen immunohistochemical staining. RESULTS: The histological results showed that both PRP-exos and PRP could promote cartilage defect repair and type II collagen formation, and the promoting effect of PRP-exos was significantly better than that of PRP. In addition, enzyme-linked immunosorbent assay (ELISA) results showed that compared with PRP, PRP-exos could significantly increase serum TIMP-1 and decrease serum MMP-3 in rats. And the promoting effect of PRP-exos was concentration dependent. CONCLUSION: Intra-articular injection of PRP-exos and PRP can promote the repair of articular cartilage defects, and the therapeutic effect of PRP-exos is better than the same concentration of PRP. PRP-exos are expected to be an effective treatment for cartilage repair and regeneration. CI - (c) 2023. The Author(s). FAU - Zhao, Hangyu AU - Zhao H AD - Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, No. 246, Xuefu Road, Nangang District, Harbin, 150001, Heilongjiang, China. AD - Department of Orthopedics, Chengdu Seventh People's Hospital, No. 1188, Shuangxing Avenue, Shuangliu District, Chengdu, 610044, Sichuan, China. FAU - Zhao, Zihang AU - Zhao Z AD - Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, No. 246, Xuefu Road, Nangang District, Harbin, 150001, Heilongjiang, China. FAU - Li, Dailuo AU - Li D AD - Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, No. 246, Xuefu Road, Nangang District, Harbin, 150001, Heilongjiang, China. FAU - Wang, Xin AU - Wang X AD - Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, No. 246, Xuefu Road, Nangang District, Harbin, 150001, Heilongjiang, China. FAU - Dai, Dehao AU - Dai D AD - Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, No. 246, Xuefu Road, Nangang District, Harbin, 150001, Heilongjiang, China. FAU - Fu, Hailiang AU - Fu H AD - Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, No. 246, Xuefu Road, Nangang District, Harbin, 150001, Heilongjiang, China. 106860696@qq.com. LA - eng PT - Journal Article DEP - 20230302 PL - England TA - J Orthop Surg Res JT - Journal of orthopaedic surgery and research JID - 101265112 RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) RN - 0 (Collagen Type II) RN - 0 (Tissue Inhibitor of Metalloproteinase-1) SB - IM MH - Animals MH - Rats MH - Rats, Sprague-Dawley MH - Matrix Metalloproteinase 3 MH - Collagen Type II MH - *Exosomes MH - Tissue Inhibitor of Metalloproteinase-1 MH - Knee Joint MH - *Platelet-Rich Plasma PMC - PMC9983202 OTO - NOTNLM OT - Cartilage defect OT - Cartilage repair OT - Exosome OT - Platelet-rich plasma COIS- The authors declare that they have no conflict of interest. EDAT- 2023/03/03 06:00 MHDA- 2023/03/07 06:00 PMCR- 2023/03/02 CRDT- 2023/03/02 23:35 PHST- 2022/09/03 00:00 [received] PHST- 2023/02/03 00:00 [accepted] PHST- 2023/03/02 23:35 [entrez] PHST- 2023/03/03 06:00 [pubmed] PHST- 2023/03/07 06:00 [medline] PHST- 2023/03/02 00:00 [pmc-release] AID - 10.1186/s13018-023-03576-0 [pii] AID - 3576 [pii] AID - 10.1186/s13018-023-03576-0 [doi] PST - epublish SO - J Orthop Surg Res. 2023 Mar 2;18(1):160. doi: 10.1186/s13018-023-03576-0.